Subscribe to our feed!

Articles of Interest

At is a running updated analysis from 2008 to April 2011  of the scientific evidence on the pros and cons of SCREENING mammography ie in women without breast symptoms or familial increased risk of breast cancer, by xray versus non-xray mammography ie breast imaging.

The Wikipedia review of mammography, although anonymous, outlines both sides of the screening mammography issue.

Since April 2011 at least seven  authoritative scientific papers  listed below  have detailed why routine xray mammography  of well breasts in women not at known increased risk gives no longterm meaningful reduction in either breast cancer nor  mortality. In fact, there is some evidence that such repeated breast crushing, irradiation, surgery and therapy may actually increase risks of breast cancer and mortality  beyond 10 years.

By contrast , as Dr Natalie Bjorklund-Gordon pleads for altenatives to xray screening, details that proven alternatives are available here and worldwide- thermomammography now highly evolved over the past 40 years, and mechanical tactile breast mapping over the past decade. As these on-line reviews detail, it is no longer ethical let alone cost-beneficial to do routine xray screening mammography on well women at any age without known increased risks.

ND Burman.

1. Utzon-Frank N, Lynge E ea  from University of Copenhagen in Cancer Epidemiol. 2011 Oct;35(5):393-8.   Balancing sensitivity and specificity: Sixteen year's of experience from the mammography screening programme in Copenhagen, show that after 14 years of xray mammography every 2 years, the incidence of new breast cancers detected actually rose by 50% compared to in the first 10 to 12 years. that comparing Norway with Sweden, Belgium with Netherlands and Eire with Ulster between 1986 and 2000, The contrast between the time differences in implementation of xray mammography screening and the similarity in reductions in mortality between the country pairs suggest that screening did not play a direct part in the reductions in breast cancer mortality.

7. And finally PhD geneticist Dr Natalie Bjorklund-Gordon June 2011 details exquisitely as a research clinical scientist